IIM
LGND icon

INTECH Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

INTECH Investment Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Sell
4,682
-1,405
-23% -$331K 0.01% 840
2026
Q1 		$1.22M Sell
6,087
-1,498
-20% -$296K 0.01% 926
2025
Q4 		$1.43M Buy
7,585
+1,473
+24% +$283K 0.01% 923
2025
Q3 		$1.08M Sell
6,112
-1,566
-20% -$233K 0.01% 1114
2025
Q2 		$873K Sell
7,678
-1,711
-18% -$183K 0.01% 1275
2025
Q1 		$987K Buy
9,389
+2,805
+43% +$317K 0.01% 1205
2024
Q4 		$705K Buy
6,584
+3,294
+100% +$372K 0.01% 1353
2024
Q3 		$329K Buy
+3,290
New +$331K ﹤0.01% 1459

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's LGND Position: Q2 2026 in Review

INTECH Investment Management reduced its Ligand Pharmaceuticals (LGND) stake by 23% in Q2 2026, selling an estimated $331K and leaving 4,682 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #840.

INTECH Investment Management first reported a position in LGND in Q3 2024 and has held it in 8 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • INTECH Investment Management held 4,682 shares of Ligand Pharmaceuticals worth $1.48M as of Q2 2026.
  • INTECH Investment Management sold 1,405 Ligand Pharmaceuticals shares in Q2 2026, an estimated $331K.
  • Ligand Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #840 holding.
  • INTECH Investment Management first reported a position in Ligand Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.